Skip to content

Clinical trials

Terminated Phase 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Phase: Phase 3 Status: Terminated Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20051
20061
20071
20101
20122
20142
20152
20191
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Ariad Pharmaceuticals2
Alliance for Clinical Trials in Oncology1
Hackensack Meridian Health1
Hospital Israelita Albert Einstein1
Prof. Dr. Nikolas von Bubnoff1
Radboud University Medical Center1
Sarit Assouline1
University Hospital, Angers1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive13
Leukemia5
Leukemia, Myeloid4
Myeloproliferative Disorders4
Bone Marrow Diseases3
Leukemia, Myeloid, Chronic-Phase3
Myelodysplastic Syndromes3
Hematologic Diseases2
Leukemia, Myeloid, Acute2
Neoplasms2

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.